There are a number of ongoing legal actions concerning patent rights that could affect the implementation of personalized medicine, such as patents on genes or tests. In an opinion piece at The Scientist, Courtenay Brinckerhoff, a partner at Foley & Lardner, writes that "the question being debated is whether these advances are most likely to flourish within the patent system or outside of it." Do patents, she asks, encourage innovation or prevent competition?

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.